USRE32919EExpiredUtility
Method of enhancing the effect of t-PA
Priority: Aug 8, 1984Filed: Jun 26, 1987Granted: May 9, 1989
Est. expiryAug 8, 2004(expired)· nominal 20-yr term from priority
A61M 5/2066A61K 38/446A61K 38/38A61K 38/49A61K 47/18A61K 31/415A61K 31/13A61M 5/19A61K 9/0019
3
PatentIndex Score
8
Cited by
8
References
7
Claims
Abstract
The absorption rate of protein-thrombolytic agents with medicinal properties in the blood is enhanced by administering the protein intramuscularly together with an absorption enhancing agent, e.g. hydroxylamine or a salt thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method of increasing the .[.absorption.]. .Iadd.effect .Iaddend.of t-PA in the blood in a mammal in need of t-Pa therapy comprising administering to the mammal .Iadd.exogenous t-PA and .Iaddend.an amount of t-PA inhibitor disassociating agent effective to increase the disassociation of the inhibitor from the t-PA, the amount of exogenous t-PA being less than that required to be administered in the absence of the inhibitor disassociating agent.
2. A method according to claim 1 wherein the inhibitor dissociating agent is added intramuscularly.
3. A method according to claim 1 wherein the inhibitor disassociating agent is added intravenously.
4. A method according to claim 1 wherein the inhibitor disassociating agent is hydroxylamine or a non-toxic salt thereof.
5. A method according to claim 4 wherein the inhibitor dissociating agent is added intramuscularly.
6. A method according to claim 4 wherein the inhibitor disassociating agent is added intravenously.
7. A method according to claim 4 wherein the inhibitor disassociating agent is hydroxylamine hydrochloride.Join the waitlist — get patent alerts
Track USRE32919E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.